Douglas Baumann, B.Sc.E.
douglas.baumann@utoronto.ca
Project Bio
One of the goals of the Shoichet group is to develop injectable drug delivery strategies for treatment of compressive spinal cord injury (SCI). Our approach to injectable drug delivery is minimally invasive, seeking to deliver a variety of neuroprotective and neuroregenerative agents in a localized and controlled manner. Our strategy is based on drug loaded hydrogels injected into the intrathecal space, immediately adjacent to the spinal cord.
With previous success in short term delivery, my project aims to extend the delivery system to 30 day release: one injection delivering a months worth of drug to the intrathecal space, diffusing into the spinal cord over time. Toward this goal I am developing an actively stabilized, injectable, and fully degradable composite biomaterial.
Employment and Education
2004 - present
Ph.D. Candidate in Chemical and Biomedical Engineering
University of Toronto
Supervisor: Dr. Molly Shoichet
2000 - 2004
B.Sc.E. in Engineering Chemistry
Queen's University
Honours Supervisors: Dr. Andrew Daugulis & Dr. Philip Jessop
2002 - 2003
Assistant Research Chemist
Cytec Canada Inc.
Supervisors: Dr. Andrew Downard & Dr. John Hillhouse
Awards
NSERC CGSD Scholarship
Wallberg Research Fellowship
